About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
HIV Medicine
›
top-articles
HIV Medicine
2.4
(top 20%)
impact factor
2.1K
(top 10%)
papers
47.7K
(top 10%)
citations
90
(top 5%)
h
-index
2.5
(top 20%)
impact factor
2.9K
all documents
50.2K
doc citations
128
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008
HIV Medicine
2008
530
2
Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy
HIV Medicine
2000
399
3
Late presentation of HIV infection: a consensus definition
HIV Medicine
2011
378
4
Relative risk of cardiovascular disease among people living with
HIV
: a systematic review and meta‐analysis
HIV Medicine
2012
346
5
Decreasing mortality and changing patterns of causes of death in the
S
wiss
HIV C
ohort
S
tudy
HIV Medicine
2013
329
6
Life expectancy of
HIV
‐positive people after starting combination antiretroviral therapy: a meta‐analysis
HIV Medicine
2017
309
7
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study
HIV Medicine
2006
296
8
Tenofovir‐associated renal and bone toxicity
HIV Medicine
2009
275
9
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort
HIV Medicine
2005
258
10
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adults
HIV Medicine
2008
239
11
The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection
HIV Medicine
2004
236
12
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults
HIV Medicine
2008
222
13
Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients
HIV Medicine
2017
216
14
A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection
HIV Medicine
2004
214
15
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)
HIV Medicine
2006
193
16
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
*
HIV Medicine
2008
189
17
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003
HIV Medicine
2005
186
18
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study
HIV Medicine
2003
181
19
HIV lipodystrophy: prevalence, severity and correlates of risk in Australia
HIV Medicine
2003
181
20
Diagnosed and undiagnosed HIV‐infected populations in Europe
HIV Medicine
2008
171
21
The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy
HIV Medicine
2006
163
22
Sexualized drug use (‘chemsex’) and high‐risk sexual behaviours in
HIV
‐positive men who have sex with men
HIV Medicine
2018
163
23
B
ritish
HIV A
ssociation guidelines for the routine investigation and monitoring of adult
HIV
‐1‐infected individuals 2011
HIV Medicine
2012
162
24
Principles and practice of HIV-protease inhibitor pharmacoenhancement
HIV Medicine
2001
159
25
British HIV Association guidelines for HIV‐associated malignancies 2008
HIV Medicine
2008
158
26
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study*
HIV Medicine
2011
154
27
Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
HIV Medicine
2008
153
28
Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers
HIV Medicine
2010
151
29
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012
HIV Medicine
2012
149
30
Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in
HIV
‐1‐infected treatment‐naïve patients in the
ARTEMIS
trial
HIV Medicine
2013
149
31
Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz
HIV Medicine
2003
148
32
Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high‐risk men who have sex with men
HIV Medicine
2009
145
33
The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study
HIV Medicine
2004
143
34
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy
HIV Medicine
2003
142
35
Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review
HIV Medicine
2020
141
36
Spectrum of chronic kidney disease in HIV‐infected patients
HIV Medicine
2009
140
37
The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy
HIV Medicine
2005
138
38
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008
HIV Medicine
2008
138
39
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV‐1 infection
HIV Medicine
2009
135
40
Abacavir and risk of myocardial infarction in HIV‐infected patients on highly active antiretroviral therapy: a population‐based nationwide cohort study
HIV Medicine
2010
134
41
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy
HIV Medicine
2003
133
42
Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients
HIV Medicine
2006
133
43
HIV/IL‐2
and
EBV
‐associated lymphoproliferative diseases: cause and effect or coincidence?
HIV Medicine
2014
132
44
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
HIV Medicine
2006
130
45
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005)
HIV Medicine
2005
129
46
The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations
HIV Medicine
2005
128
47
The
CD
4:
CD
8 ratio is associated with markers of age‐associated disease in virally suppressed
HIV
‐infected patients with immunological recovery
HIV Medicine
2014
124
48
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients
HIV Medicine
2005
123
49
Immune activation in the course of
HIV
‐1 infection: Causes, phenotypes and persistence under therapy
HIV Medicine
2016
123
50
Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV
HIV Medicine
2021
123
site/software ©
exaly
; All materials licenced under
CC by-SA
.